Expression and autoregulation of transforming growth factor β receptor mRNA in small-cell lung cancer cell lines

British Journal of Cancer

Volumn 73, Issue 9, 1996, Pages 1037-1043

  Norgaard P ^a,b   Spang Thomsen, M ^b   Poulsen, H S ^a  

^a FINSEN LABORATORY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Autoregulation; Cell line; Growth factor beta receptor; Small cell lung cancer; Transforming; Transforming growth factor beta receptor mRNA

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; AUTOREGULATION; CANCER CELL CULTURE; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GROWTH INHIBITION; LUNG SMALL CELL CANCER; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RECEPTOR GENE; SOUTHERN BLOTTING;

EID: 0029874364     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.201     Document Type: Article

References (46)

1. AARONSON SA. (1991). Growth factors and cancer. Science, 254, 1146-1153.
2. ASSOIAN RK, FROLIK CA, ROBERTS AB, MILLER DM AND SPORN MB. (1984). Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblasts. Cell, 36, 35-41.
3. ATTISANO L, CÁRCAMO J, VENTURA F, WEIS FMB, MASSAGUÉ J AND WRANA JL.(1993). Identification of human activin and TGFβ type I receptors that form heterodimeric kinase complexes with type II receptors. Cell, 75, 671-680.
4. ATTISANO L, WRANA JL, LÓPEZ-CASILLAS F AND MASSAGUÉ J. (1994). TGF-β receptors and actions. Biochim. Biophys. Acta, 1222, 71-80.
5. BERENDSEN HH, DE LEIJ L, DE VRIES EGE, MESANDER G, MULDER NH, DE JONG B, BUYS CHCM, POSTMUS PE, POPPEMA S, SLUITER HJ AND THE HT (1988). Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res., 48, 6891-6899.
6. BOYD FT AND MASSAGUÉ J. (1989). Transforming growth factor-β inhibition of epithelial cell proliferation is linked to the expression of a 53-kDa membrane receptor. J. Biol. Chem., 264, 2272-2278.
7. CHIRGWIN JM, PRZYBYLA AE, MACDONALD RJ AND RUTTER WJ. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299.
8. DAMSTRUP L, RYGAARD K, SPANG-THOMSEN M AND POULSEN HS. (1993). Expression of the transforming growth factor β (TGF-β) receptors and TGF-β1, TGF-β2, and TGF-β3 in human small cell lung cancer cell lines. Br. J. Cancer, 67, 1015-1021.
9. DE LEIJ L, POSTMUS PE, BUYS CHCM, ELEMA JD, RAMAEKERS F, POPPEMA S, BROUWER M, VAN DER VEEN AY, MESANDER G AND THE TH. (1985). Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res., 45, 6024-6033.
10. EBNER R, CHEN R-H, LAWLER S, ZIONCHECK T AND DERYNCK R. (1993a). Determination of type I receptor specificity by the type II receptor for TGF-β or activin. Science, 262, 900-902.
11. EBNER R, CHEN R-H, SHUM L, LAWLER S, ZIONCHECK TF, LEE A, LOPEZ AR AND DERYNCK R. (1993b). Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science, 260, 1344-1348.
12. EDWARDS DR, PARFETT CL AND DENHARDT DT. (1985). Transcriptional regulation of two serum-induced RNAs in mouse fibroblasts: Equivalence of one species to B2 repetitive elements. Mol. Cell. Biol., 5, 3280-3288.
13. ENGELHOLM SA, SPANG-THOMSEN M, VINDELØV LL, BRÜNNER N, NIELSEN MH, HIRSCH F AND HANSEN HH. (1986). Comparison of characteristics of human small cell carcinoma of the lung in patients, in vitro and transplanted into nude mice. Acta Pathol. Microbiol. Scand. Sect. A Pathol., 94, 325-336.
14. FEINBERG AP AND VOGELSTEIN B. (1983). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132, 6-13.
15. FRANZÉN P, TEN DIJKE P, ICHIJO H, YAMASHITA H, SCHULZ P, HELDIN C-H AND MIYAZONO K. (1993). Cloning of a TGF-β type I receptor that forms a heteromeric complex with the type II receptor. Cell, 75, 681-692.
16. GEISER AG, BURMESTER JK, WEBBINK R, ROBERTS AB AND SPORN MB. (1992). Inhibition of growth by transforming growth factor-β following fusion of two nonresponsive human carcinoma cell lines. J. Biol. Chem., 267, 2588-2593.
17. INAGAKI M, MOUSTAKAS A, LIN HY, LODISH HF AND CARR BI. (1993). Growth inhibition by transforming growth factor β (TGF-β) type I is restored in TGF-β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc. Natl Acad. Sci. USA, 90, 5359-5363.
18. INAGAKI M, WANG ZQ AND CARR BI. (1994). Transforming growth factor beta 1 selectively increases gene expression of the serine/ threonine kinase receptor 1 (SKR1) in human hepatoma cell lines. Cell Struct. Fund., 19, 305-313.
19. KADIN ME, CACAILLE-COLL MW, GERTZ R, MASSAGUÉ J, CHEIFETZ S AND GEORGE D. (1994). Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc. Natl Acad. Sci. USA, 91, 6002-6006.
20. KIKUCHI K, YAMAKAGE A, SMITH EA, LEROY EC AND TROJANOWSKA M. (1992). Differential modulation of bFGF receptors by TGF-β in adult skin, scleroderma skin and newborn foreskin fibroblasts. J. Invest. Dermatol., 99, 201-205.
21. KINGSLEY DM. (1994). The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev., 8, 133-146.
22. LAIHO M, WEIS FM, BOYD FT, IGNOTZ RA AND MASSAGUÉ J. (1991). Responsiveness of transforming growth factor-β restored by complementation between cells defective in TGF-β receptors I and II. J. Biol. Chem., 266, 9108-9112.
23. LEOF EB, PROPER JA, GOUSTIN AS, SHIPLEY GD, DICORLETO PE AND MOSES HL. (1986). Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl Acad. Sci. USA, 83, 2453-2457.
24. LIN HY, WANG X-F, NG-EATON E, WEINBERG RA AND LODISH HF. (1992). Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68, 775-785.
25. LÓPEZ-CASILLAS F, CHEIFETZ S, DOODY J, ANDRES JL, LANE WS AND MASSAGUÉ J. (1991). Structure and expression of the membrane proteoglycan, a component of the TGF-β receptor system. Cell, 67, 785-795.
26. LÓPEZ-CASILLAS F, WRANA JL AND MASSAGUÉ J. (1993). Betaglycan presents ligand to the TGF-β signalling receptor. Cell, 73, 1435-1444.
27. MARKOWITZ S, WANG J, MYEROFF L, PARSONS R, SUN L, LUTTERBAUGH J, FAN RS, ZBOROWSKA E, KINZLER KW, VOGELSTEIN B, BRATTAIN M AND WILLSON JKV. (1995). Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-1338.
28. MASSAGUÉ J. (1985). Transforming growth factor-β modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-alpha. J. Cell Biol., 100, 1508-1514.
29. MASSAGUÉ J. (1990). The transforming growth factor-β family. Annu. Rev. Cell Biol., 6, 597-641.
30. MORÉN A, ICHIJO H AND MIYAZONO K. (1992). Molecular cloning and characterization of the human and porcine transforming growth factor-β type III receptors. Biochem. Biophys. Res. Comm., 189, 356-362.
31. MOSES HL. (1992). TGF-beta regulation of epithelial cell proliferation. Mol. Reprod. Dev., 32, 179-184.
32. MOUSTAKAS A, LIN HY, HENIS YI, PLAMONDON J, O'CONNOR-MCCOURT MD AND LODISH HF. (1993). The transforming growth factor β receptors types I, II and III form heterooligomeric complexes in the presence of ligand. J. Biol. Chem., 268, 22215-22218.
33. NØRGAARD P, DAMSTRUP L, RYGAARD K, SPANG-THOMSEN M AND POULSEN HS. (1994). Growth suppression by transforming growth factor-β1 of human small cell lung cancer cell lines is associated to expression of the type II receptor. Br. J. Cancer, 69, 802-808.
34. NØRGAARD P, HOUGAARD S, SPANG-THOMSEN M AND POULSEN HS. (1995). Transforming growth factor β and cancer. Cancer Treat. Rev., 21, 367-403.
35. PARK K, KIM S-J, BANG Y-J, PARK J-G, KIM NK, ROBERTS AB AND SPORN, MB. (1994). Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl Acad. Sci. USA, 91, 8772-8776.
36. PETTENGILL OS, SORENSON GD, WURSTER-HILL D, CURPHEY TJ, NOLL WW, CATE CC AND MAURER LH. (1980). Isolation and growth characteristics of continous cell lines from small-cell carcinoma of the lung. Cancer. 45, 906-918.
37. ROBERTS AB AND SPORN MB. (1990). The transforming growth factor-βs. In Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors, Sporn MB and Roberts AB. (eds.) pp.419-472. Springer: Heidelberg.
38. SAMBROOK J, FRITSCH EF AND MANIATIS T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY.
39. SORENSON GD, PFTTENGILL OS, CATE CC AND DELPRETE SA. (1984). Biomarkers in small cell carcinoma of the lung. In Lung Cancer, Aisner J (ed.) pp.203-240. Churchill Livingstone: New York.
40. TEN DIJKE P, YAMASHITA H, ICHUO H, FRANZÉN P, LAIHO M, MIYAZONO K AND HELDIN C-H. (1994). Characterization of type I receptors for transforming growth factor-β and activin. Science, 264, 101-104.
41. VAN OBBERGHEN-SCHILLING E, ROCHE NS, FLANDERS KC, SPORN MB AND ROBERTS AB. (1988). Transforming growth factor β1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem., 263, 7741-7746.
42. WANG X-F, LIN HY, NG-EATON E, DOWNWARD J, LODISH HF AND WEINBERG RA. (1991). Expression cloning and characterization of the TGF-β type III receptor. Cell, 67, 797-805.
43. WIN KM, CHARLOTTE F, MALLAT A, CHERQUI D, MARTIN N, MAVIER P, PREAUX A-M, DHUMEAUX D AND ROSENBAUM J. (1993). Mitogenic effect of transforming growth factor-β1 on human ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. Hepatology, 18, 137-145.
44. WRANA JL, ATTISANO L, CÁRCAMO J, ZENTELLA A, DOODY J, LAIHO M, WANG X-F AND MASSAGUÉ J. (1992). TGFβ signals through a heteromeric protein kinase complex. Cell, 71, 1003-1014.
45. WRANA JL, ATTISANO L, WIESER F, VENTURA F AND MASSAGUÉ J. (1994). Mechanism of activation of the TGF-β receptor. Nature, 370, 341-347.
46. YAMASHITA H, TEN DIJKE P, FRANZÉN P, MIYAZONO K AND HELDIN C-H. (1994). Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol. Chem., 269, 20172-20178.